Board Appointment
Board Appointment
Perth, Jan 8, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to announce the appointment of Michael Curtis as a non-executive director, effective immediately.

Mr. Curtis resides in Toronto, Canada and is an experienced former investment banker and private equity executive. He is an active cannabis sector executive, having recently served as VP of Corporate Finance of Dosecann (an investee company prior to its successful divestment by MMJ earlier this year) and now as the Chief Operating Officer of and a Director of Embark Health (a current investee company of MMJ). His experience and key appointment terms are summarised in the attachment to this release.

Commenting on this appointment, MMJ's Chairman Peter Wall said "We are pleased to have attracted Michael Curtis to our board. He is an experienced Canada-based cannabis sector executive with skills that complement those of the board and which will be valuable as MMJ continues to grow as a cannabis investment company. Through the course of this year Michael has also built rapport with both the board and our CEO Jason Conroy through our investments in each of Dosecann and Embark Health."

To view the attachment, please visit:

About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit:



Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819

Related Companies

MMJ Group Holdings Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 55) (Last 30 Days: 236) (Since Published: 2332) 

MMJ Group Holdings Ltd NEWS: RECENT VISITS (49325)

Research Report

Social Media